Experiment summary for ENCSR282NLQ
doi:10.17989/ENCSR282NLQ
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- TSHZ2
- Biosample summary
- Homo sapiens SK-N-SH genetically modified (insertion) using CRISPR targeting H. sapiens TSHZ2 treated with 6 μM all-trans-retinoic acid for 48 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- eGFP-TSHZ2 ChIP-seq on human SK-N-SH
- Treatments
- 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hours
- Nucleic acid type
- DNA
- Size range
- 250-450
- Fragmentation methods
- sonication (Bioruptor Pico)
- Platform
- Illumina HiSeq 4000
- Controls
Attribution
ENCODE4 project
- Lab
- Michael Snyder, Stanford
- Award
- UM1HG009442 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:pCS-14, michael-snyder:pCS-eGFP-TSHZ2 SK-N-SH ChIP
- Date submitted
- December 22, 2018
- Date released
- June 30, 2020
- Annotation (gkmsvm-model)
- Annotation (BPNet-model)
- Tags
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Antibody | Library |
|---|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens TSHZ2 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS657ZAZ | ENCGM733YIG | ENCAB728YTO | ENCLB383ZDI |
| 2 | 1 | Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting H. sapiens TSHZ2 treated with 6 μM all-trans-retinoic acid for 48 hours | ENCBS743KWD | ENCGM733YIG | ENCAB728YTO | ENCLB752BUU |